Clinical Trial Update: Study Comparing Caspofungin to Placebo for the Treatment of ICU Intra-abdominal Candidiasis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing caspofungin to placebo for treating ICU-associated intra-abdominal candidiasis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intra-abdominal Candidiasis
• Intra-abdominal Infection

Drugs mentioned

• Caspofungin (caspofungin)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: ICU Yeast Intra-abdominal Infection | Phase 3 | Status: RECRUITING